224 related articles for article (PubMed ID: 22906987)
21. CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.
Erhardt A; Wegscheid C; Claass B; Carambia A; Herkel J; Mittrücker HW; Panzer U; Tiegs G
J Immunol; 2011 May; 186(9):5284-93. PubMed ID: 21441449
[TBL] [Abstract][Full Text] [Related]
22. Chemokine-Regulated Recruitment of Antigen-Specific T-Cell Subpopulations to the Liver in Acute and Chronic Hepatitis C Infection.
Pirozyan MR; Nguyen N; Cameron B; Luciani F; Bull RA; Zekry A; Lloyd AR
J Infect Dis; 2019 Apr; 219(9):1430-1438. PubMed ID: 30496498
[TBL] [Abstract][Full Text] [Related]
23. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
24. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants.
Goddard S; Williams A; Morland C; Qin S; Gladue R; Hubscher SG; Adams DH
Transplantation; 2001 Dec; 72(12):1957-67. PubMed ID: 11773896
[TBL] [Abstract][Full Text] [Related]
26. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.
Odegard JM; DiPlacido LD; Greenwald L; Kashgarian M; Kono DH; Dong C; Flavell RA; Craft J
J Immunol; 2009 Apr; 182(7):4076-84. PubMed ID: 19299705
[TBL] [Abstract][Full Text] [Related]
27. Dual role for CXCR3 and CCR5 in asthmatic type 1 inflammation.
Gauthier M; Kale SL; Oriss TB; Scholl K; Das S; Yuan H; Hu S; Chen J; Camiolo M; Ray P; Wenzel S; Ray A
J Allergy Clin Immunol; 2022 Jan; 149(1):113-124.e7. PubMed ID: 34146578
[TBL] [Abstract][Full Text] [Related]
28. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.
Burns WR; Wang Y; Tang PC; Ranjbaran H; Iakimov A; Kim J; Cuffy M; Bai Y; Pober JS; Tellides G
Am J Transplant; 2005 Jun; 5(6):1226-36. PubMed ID: 15888026
[TBL] [Abstract][Full Text] [Related]
29. Expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells in CBA/JxDBA/2 mouse model, selectively induced by IL-4 and IL-10, regulates the embryo resorption rate.
Jiang PJ; Zhao AM; Bao SM; Xiao SJ; Xiong M
Chin Med J (Engl); 2009 Aug; 122(16):1917-21. PubMed ID: 19781371
[TBL] [Abstract][Full Text] [Related]
30. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
Manicone AM; Burkhart KM; Lu B; Clark JG
Exp Lung Res; 2008 Sep; 34(7):391-407. PubMed ID: 18716926
[TBL] [Abstract][Full Text] [Related]
31. CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions.
Rabin RL; Alston MA; Sircus JC; Knollmann-Ritschel B; Moratz C; Ngo D; Farber JM
J Immunol; 2003 Sep; 171(6):2812-24. PubMed ID: 12960302
[TBL] [Abstract][Full Text] [Related]
32. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
Qin S; Rottman JB; Myers P; Kassam N; Weinblatt M; Loetscher M; Koch AE; Moser B; Mackay CR
J Clin Invest; 1998 Feb; 101(4):746-54. PubMed ID: 9466968
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
34. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
35. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
[TBL] [Abstract][Full Text] [Related]
36. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.
Cripps JG; Wang J; Maria A; Blumenthal I; Gorham JD
Hepatology; 2010 Oct; 52(4):1350-9. PubMed ID: 20803559
[TBL] [Abstract][Full Text] [Related]
37. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
38. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
Front Immunol; 2018; 9():1090. PubMed ID: 29868034
[TBL] [Abstract][Full Text] [Related]
39. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
40. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.
Loiseau C; Requena M; Nayrac M; Mavigner M; Cazabat M; Iscache AL; Carrere N; Suc B; Alric L; Izopet J; Delobel P
J Infect Dis; 2019 Jul; 220(5):830-840. PubMed ID: 30880342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
